Quarterly report pursuant to Section 13 or 15(d)

Restatement of Previously Issued Financial Statements (Tables)

v3.7.0.1
Restatement of Previously Issued Financial Statements (Tables)
3 Months Ended
Mar. 31, 2017
Restatement of Previously Issued Financial Statements [Abstract]  
Schedule of Condensed Consolidated Balance Sheets
    As of March 31, 2017  
    As previously              
    Reported     Adjustment     Restated  
ASSETS                  
Current assets:                  
Cash   $ 9,485     $ -     $ 9,485  
Total current assets:     9,485       -       9,485  
                         
Total assets   $ 9,485     $ -     $ 9,485  
                         
LIABILITIES AND STOCKHOLDERS’ DEFICIT                        
Current liabilities:                        
Accounts payable   $ 419,859     $ -     $ 419,859  
Accrued interest payable     34,763       -       34,763  
Note payable, net of debt discount $1,517 and $1,517, respectively     145,483       -       145,483  
Note payable – related parties     16,000       -       16,000  
Convertible note payable     121,000       -       121,000  
Fair value of derivative liability - beneficial conversion feature     46,476       -       46,476  
Deposit     -       -       -  
Total current liabilities     783,581       -       783,581  
                         
Total liabilities     783,581       -       783,581  
                         
Stockholders’ deficit:                        
Preferred stock authorized 25,000,000 shares, $.0001 par value, no shares issued and outstanding at March 31, 2017 and December 31, 2016.     -       -       -  
Common stock authorized 100,000,000 shares, $.0001 par value, 51,411,443 shares issued and outstanding at March 31, 2017 and December 31, 2016.     5,141       -       5,141  
Additional paid-in capital     4,401,221       (177,493 )     4,223,728  
Accumulated deficit     (5,180,458 )     177,493       (5,002,965 )
Total stockholders’ deficit     (774,096 )     -       (774,096 )
                         
Total liabilities and stockholders’ deficit   $ 9,485     $ -     $ 9,485
Schedule of Condensed Consolidated Statements of Operations
    For the Three Months Ended March 31, 2017  
    As Previously              
    Report     Adjustment     Restated  
                   
                   
NET SALES   $ -     $ -     $ -  
                         
OPERATING EXPENSES:                        
Professional fees     96,222       -       96,222  
Selling, general, and administrative     10,191       -       10,191  
Total Operating Expenses     106,413       -       106,413  
                         
Loss from operations     (106,413 )     -       (106,413 )
                         
OTHER INCOME (EXPENSE):                        
    Other Income     1,775       -       1,775  
Gain on the sale of subsidiary     -       177,493       177,493  
Interest expense     (6,195 )     -       (6,195 )
Changes in fair value of derivative     (7,720 )     -       (7,720 )
Total Other Income (Expenses), net     (12,140 )     177,493       165,353  
                         
NET INCOME/LOSS   $ (118,553 )   $ 177,493     $ 58,940  
                         
NET INCOME/LOSS PER BASIC SHARES   $ 0.00     $ -     $ 0.00  
                         
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING – BASIC     51,411,443               51,411,443  
                         
NET INCOME/(LOSS) PER DILUTED SHARES   $ 0.00     $ -     $ 0.00  
                         
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING –DILUTED   $ 51,411,443     $ 15,648,651     $ 67,060,094
Schedule of Condensed Consolidated Statements of Cash Flows
    For the Three Months Ended March 31, 2017  
    As Previously              
    Report     Adjustment     Restated  
                   
Operating Activities:                  
Net income/(loss)   $ (118,553 )   $ 177,493     $ 58,940  
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:                        
    Change in deposit balance     44,522       (222,015 )     (177,493 )
Stock based compensation     48,558       -       48,558  
Interest expense – note payable     3,439       -       3,439  
    Interest expense – amortization of convertible note discount     2,554       -       2,554  
    Changes in fair value of convertible note     7,720       -       7,720  
    Accounts payable     11,946       -       11,946  
    Deposit     -       44,522       44,522  
Net cash provided by operating activities     186       -       186  
                         
Financing Activities:                        
Proceeds from issuance of note payable     -       -       -  
Net cash provided by financing activities     -       -       -  
                         
Net increase (decrease) in cash     186       -       186  
                         
Cash, Beginning of period     9,299       -       9,299  
                         
Cash, End of period   $ 9,485     $ -     $ 9,485